(Q42679895)

English

Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation.

scientific article published on 30 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Bente Jespersen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Lars Mjörnstedt

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Søren Schwartz Sørensen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Bengt von Zur Mühlen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jesper M Hansen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Helene Andersson

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Bengt Gustafsson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Dag Solbu

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Hallvard Holdaas

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

30 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Transplant International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

42-51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Chronic calcineurin inhibitor nephrotoxicity-lest we forget

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Reduced exposure to calcineurin inhibitors in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Calcineurin inhibitor sparing in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Performance of creatinine-based estimates of GFR in kidney transplant recipients: a systematic review.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Progression of graft fibrosis under mammalian target of rapamycin inhibitor-based regimen

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimen.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12437

21 January 2018

Identifiers

10.1111/TRI.12437

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25176389%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42679895&oldid=1578697500"